甲状腺透明质小梁瘤1例报告及文献复习

Q4 Medicine 肿瘤研究与临床 Pub Date : 2020-02-28 DOI:10.3760/CMA.J.ISSN.1006-9801.2020.02.012

Jin-xiang Huang, Nong Cao

{"title":"甲状腺透明质小梁瘤1例报告及文献复习","authors":"Jin-xiang Huang, Nong Cao","doi":"10.3760/CMA.J.ISSN.1006-9801.2020.02.012","DOIUrl":null,"url":null,"abstract":"目的 \n提高对甲状腺透明变梁状肿瘤（HTT）的认识，掌握其诊断和治疗。 \n \n \n方法 \n回顾性分析2019年5月兰州大学第一医院收治的1例HTT患者的临床资料，并进行文献复习。 \n \n \n结果 \n该患者主要临床表现为颈部肿物渐进性增大、胸闷、气短等，入院行左侧甲状腺切除术，其病理及免疫组织化学证实为HTT伴微小乳头状癌。 \n \n \n结论 \nHTT是一种具有潜在低度恶性的甲状腺肿瘤，最大特点是具有小梁状的玻璃样变性，外科手术是主要治疗手段。","PeriodicalId":9505,"journal":{"name":"肿瘤研究与临床","volume":"32 1","pages":"125-127"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hyalinizing trabecular tumor of the thyroid: report of one case and review of literature\",\"authors\":\"Jin-xiang Huang, Nong Cao\",\"doi\":\"10.3760/CMA.J.ISSN.1006-9801.2020.02.012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"目的 \\n提高对甲状腺透明变梁状肿瘤（HTT）的认识，掌握其诊断和治疗。 \\n \\n \\n方法 \\n回顾性分析2019年5月兰州大学第一医院收治的1例HTT患者的临床资料，并进行文献复习。 \\n \\n \\n结果 \\n该患者主要临床表现为颈部肿物渐进性增大、胸闷、气短等，入院行左侧甲状腺切除术，其病理及免疫组织化学证实为HTT伴微小乳头状癌。 \\n \\n \\n结论 \\nHTT是一种具有潜在低度恶性的甲状腺肿瘤，最大特点是具有小梁状的玻璃样变性，外科手术是主要治疗手段。\",\"PeriodicalId\":9505,\"journal\":{\"name\":\"肿瘤研究与临床\",\"volume\":\"32 1\",\"pages\":\"125-127\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"肿瘤研究与临床\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2020.02.012\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"肿瘤研究与临床","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2020.02.012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

目的提高对甲状腺透明变梁状肿瘤（HTT）的认识，掌握其诊断和治疗。方法回顾性分析2019年5月兰州大学第一医院收治的1例HTT患者的临床资料，并进行文献复习。结果该患者主要临床表现为颈部肿物渐进性增大、胸闷、气短等，入院行左侧甲状腺切除术，其病理及免疫组织化学证实为HTT伴微小乳头状癌。结论 HTT是一种具有潜在低度恶性的甲状腺肿瘤，最大特点是具有小梁状的玻璃样变性，外科手术是主要治疗手段。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Hyalinizing trabecular tumor of the thyroid: report of one case and review of literature

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

相关文献

二甲双胍通过HDAC6和FoxO3a转录调控肌肉生长抑制素诱导肌肉萎缩

IF 8.9 1区医学Journal of Cachexia, Sarcopenia and MusclePub Date : 2021-11-02 DOI: 10.1002/jcsm.12833

Min Ju Kang, Ji Wook Moon, Jung Ok Lee, Ji Hae Kim, Eun Jeong Jung, Su Jin Kim, Joo Yeon Oh, Sang Woo Wu, Pu Reum Lee, Sun Hwa Park, Hyeon Soo Kim

具有疾病敏感单倍型的非亲属供体脐带血移植后的1型糖尿病

IF 3.2 3区医学Journal of Diabetes InvestigationPub Date : 2022-11-02 DOI: 10.1111/jdi.13939

Kensuke Matsumoto, Taisuke Matsuyama, Ritsu Sumiyoshi, Matsuo Takuji, Tadashi Yamamoto, Ryosuke Shirasaki, Haruko Tashiro

封面:蛋白质组学分析确定IRSp53和fastin是PRV输出和直接细胞-细胞传播的关键

IF 3.4 4区生物学ProteomicsPub Date : 2019-12-02 DOI: 10.1002/pmic.201970201

Fei-Long Yu, Huan Miao, Jinjin Xia, Fan Jia, Huadong Wang, Fuqiang Xu, Lin Guo

来源期刊

肿瘤研究与临床 Medicine-Oncology

CiteScore

0.10

自引率

0.00%

发文量

7737

期刊介绍： "Cancer Research and Clinic" is a series of magazines of the Chinese Medical Association under the supervision of the National Health Commission and sponsored by the Chinese Medical Association. It mainly reflects scientific research results and academic trends in the field of malignant tumors. The main columns include monographs, guidelines and consensus, standards and norms, treatises, short treatises, survey reports, reviews, clinical pathology (case) discussions, case reports, etc. The readers are middle- and senior-level medical staff engaged in basic research and clinical work on malignant tumors.